Considerable increases were seen in reported cases of syphilis and gonorrhoea in 2023, relative to 2022, and continues the increasing trend seen in 2022. These trends underscore the need for immediate action to prevent further transmission and mitigate the impact of STIs on public health.
Increase in carbapenem-resistant Enterobacterales (CRE)
Increasing incidence of bloodstream infections with Enterobacterales resistant to carbapenem antibiotics poses a significant threat to patients and healthcare systems in the EU/EEA.
Poliovirus detections in sewage call for vigilance
While the EU/EEA remains polio-free, recent detections of poliovirus in wastewater samples in the EU/EEA call for safeguarding high polio vaccination coverage and addressing vaccination gaps.
Avian influenza viruses pose an increasing threat, with the potential to adapt to humans and trigger future pandemics. Employing a One Health approach, ECDC and EFSA have issued scientific advice that assesses avian influenza virus mutations and the potential of these viruses to spread to humans, along with recommendations for the animal and public health sectors.
For 2023, 96 969 confirmed cases of gonorrhoea were reported in 28 European Union/European Economic Area (EU/EEA) countries, with a crude notification rate of 25.0 cases per 100 000 population, representing a 31% increase in the crude notification rate compared with 2022.
In 2023, 78 confirmed congenital syphilis cases were reported from 13 EU/EEA countries, while 13 other countries reported no cases. For 2022, 73 cases were reported by 14 out of 25 countries contributing data.
Join the ECDC Crowd and work on improving and transforming health science one task at a time with your insights on study design, statistical analysis, data collection and interpretation
About ECDC
ECDC collects, analyses and shares data on more than 50 infectious disease topics. ECDC experts assess risks to Europe and provide guidance to help countries prevent and respond to outbreaks and public health threats.